FDA Inspection 1319558 — We Are Blood
The FDA completed an inspection of We Are Blood on May 14, 2026 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 14, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Austin, TX (United States)